Pacific Biosciences of California Inc (NASDAQ: PACB) kicked off on Tuesday, up 6.32% from the previous trading day, before settling in for the closing price of $0.99. Over the past 52 weeks, PACB has traded in a range of $0.85-$2.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 11.12%. While this was happening, its average annual earnings per share was recorded 0.84%. With a float of $264.16 million, this company’s outstanding shares have now reached $300.04 million.
Let’s determine the extent of company efficiency that accounts for 575 employees. In terms of profitability, gross margin is 16.17%, operating margin of -519.0%, and the pretax margin is -431.71%.
Pacific Biosciences of California Inc (PACB) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 11.97%, while institutional ownership is 65.68%. The most recent insider transaction that took place on May 19 ’25, was worth 5,200. In this transaction an insider of this company sold 5,195 shares at a rate of $1.00, taking the stock ownership to the 269,259 shares. Before that another transaction happened on Mar 03 ’25, when Company’s insider sold 12,497 for $1.41, making the entire transaction worth $17,583. This insider now owns 2,225,357 shares in total.
Pacific Biosciences of California Inc (PACB) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.96% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Take a look at Pacific Biosciences of California Inc’s (PACB) current performance indicators. Last quarter, stock had a quick ratio of 5.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.77, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Looking closely at Pacific Biosciences of California Inc (NASDAQ: PACB), its last 5-days average volume was 11.67 million, which is a jump from its year-to-date volume of 10.29 million. As of the previous 9 days, the stock’s Stochastic %D was 50.14%. Additionally, its Average True Range was 0.09.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 14.60%, which indicates a significant decrease from 66.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.79% in the past 14 days, which was higher than the 95.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1460, while its 200-day Moving Average is $1.5945. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $1.1033. Second resistance stands at $1.1567. The third major resistance level sits at $1.2233. If the price goes on to break the first support level at $0.9833, it is likely to go to the next support level at $0.9167. Should the price break the second support level, the third support level stands at $0.8633.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
The company with the Market Capitalisation of 315.09 million has total of 300,085K Shares Outstanding. Its annual sales at the moment are 154,010 K in contrast with the sum of -309,850 K annual income. Company’s last quarter sales were recorded 37,150 K and last quarter income was -426,080 K.
